Pharmacokinetic evaluation of a new oral sustained release dosage form of tramadol

British Journal of Clinical Pharmacology

Volumn 57, Issue 3, 2004, Pages 270-278

  Malonne, H ^a   Sonet, B ^b   Streel, B ^b   Lebrun, S ^b   De Niet, S ^b   Sereno, A ^b   Vanderbist, F ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Laboratoires SMB SA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; O NORTRAMADOL; TRAMADOL; UNCLASSIFIED DRUG;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DETERMINATION; DRUG SCREENING; ENANTIOMER; FEEDING; FEMALE; FOOD INTAKE; FRIEDMAN TEST; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANK SUM TEST; STATISTICAL ANALYSIS; STEADY STATE; SUSTAINED RELEASE PREPARATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANALGESICS, OPIOID; BIOLOGICAL AVAILABILITY; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; TRAMADOL;

EID: 1542299787     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2003.02013.x     Document Type: Article

References (30)

1. Lee CR, McTavish D, Sorkin EM. Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs 1993; 46: 313-40.
2. Collart L, Luthy C, Favario-Constantin C, Dayer P. [Duality of the analgesic effect of tramadol in humans]. Schweiz Med 1993; 123: 2241-3.
3. Dayer P, Collart L, Desmeules J. The pharmacology of tramadol. Drugs 1994; 47(Suppl 1): 3-7.
4. Desmeules JA, Piguet V, Collart L, Dayer P. Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Pharmacol 1996; 41: 7-12.
5. Driessen B, Reimann W, Giertz H. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br J Pharmacol 1993; 108: 806-11.
6. Raffa RB, Friderichs E, Reimann W et al. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 1993; 267: 331-40.
7. Wilder-Smith CH, Bettiga A. The analgesic tramadol has minimal effect on gastrointestinal motor function. Br J Clin Pharmacol 1997; 43: 71-5.
8. Driessen B, Reimann W. Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol 1992; 105: 147-51.
9. Lintz W, Erlacin S, Frankus E, Uragg H. [Biotransformation of tramadol in man and animal (author's transl)]. Arzneimittelforschung 1981; 31: 1932-43.
10. Lintz W, Barth H, Osterloh G, Schmidt-Bothelt E. Bioavailability of enterai tramadol formulations. 1st communication: capsules. Arzneimittelforschung 1986; 36: 1278-83.
11. Ehrenreich H, Poser W. Dependence on tramadol. Clin Invest 1993; 72: 76.
12. Murthy BV, Pandya KS, Booker PD, Murray A, Lintz W, Terlinden R. Pharmacokinetics of tramadol in children after i.v. or caudal epidural administration. Br J Anaesth 2000; 84: 346-9.
13. Preston KL, Jasinski DR, Testa M. Abuse potential and pharmacological comparison of tramadol and morphine. Drug Alcohol Depend 1991; 27: 7-17.
14. Bamigbade TA, Langford RM. Tramadol hydrochloride: an overview of current use. Hosp Med 1998; 59: 373-6.
15. Lintz W, Barth H, Osterloh G, Schmidt-Bothelt E. Pharmacokinetics of tramadol and bioavailability of enterai tramadol formulations. 3rd Communication: suppositories. Arzneimittelforschung 1998; 48: 889-99.
16. Lintz W, Barth H, Becker R, Frankus E, Schmidt-Bothelt E. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol. Arzneimittelforschung 1998; 48: 436-45.
17. Lintz W, Beier H, Gerloff J. Bioavailability of tramadol after i.m. injection in comparison to i.v. infusion. Int J Clin Pharmacol Ther 1999; 37: 175-83.
18. Lintz W, Becker R, Gerloff J, Terlinden R. Pharmacokinetics of tramadol and bioavailability of enterai tramadol formulations. 4th communication: drops (without ethanol). Arzneimittelforschung 2000; 50: 99-108.
19. Malonne H, Fontaine J, Moes A. In vitro/in vivo characterization of a tramadol HCl depot system composed of monoolein and water. Biol Pharm Bull 2000; 23: 627-31.
20. Raber M, Schulz HU, Schurer M, Bias-Imhoff U, Momberger H. Pharmacokinetic properties of tramadol sustained release capsules. 2nd communication: investigation of relative bioavailability and food interaction. Arzneimittelforschung 1999; 49: 588-93.
21. Raber M, Schulz HU, Schurer M, Krupp S, Momberger H. Pharmacokinetic properties of tramadol sustained release capsules. 3rd communication: investigation of relative bioavailability under steady state conditions. Arzneimittelforschung 1999; 49: 594-8.
22. Ceccato A, Vanderbist F, Pabst JY, Streel B. Enantiomeric determination of tramadol and its main metabolite O-desmethyltramadol in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl 2000; 748: 65-76.
23. Gibaldi M, Perrier D. Pharmacokinetics, 2nd edn. Edition, New York: M. Dekker 1992.
24. Hauschke D, Steinijans VW, Diletti E. A distribution-free procedure for the statistical analysis of bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 1992; 30(Suppl 1): S37-S43.
25. Steinijans VW, Diletti E. Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals. Eur J Clin Pharmacol 1983; 24: 127-36.
26. Steinijans VW, Diletti E. Generalization of distribution - free confidence intervals for bioavailability ratios. Eur J Clin Pharmacol 1985; 28: 85-8.
27. Portenoy RK. Current pharmacotherapy of chronic pain. J Pain Symptom Manage 2000; 19: S16-S20.
28. Wilder-Smith CH, Hill L, Spargo K, Kalla A. Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID's: a randomised study comparing analgesia, antinociception and gastrointestinal effects. Pain 2001; 91: 23-31.
29. Malonne H, Coffiner M, Sonet B, De Niet S, Lebrun S, Vanderbist F. Randomised multicentre double-blind placebo-controlled study comparing the efficacy of slow release tramadol with immediate release tramadol in the treatment of symptomatic osteoarthritis of the knee and of the hip. Osteoarthritis Cartilage. 2003; 11: S118.
30. Malonne H, Coffiner M, Sonet B De Niet S, Lebrun S, Peretz A, Vanderbist F. Open, international, multicentre, PHASE III trial on the safety of a long-term treatment with a new sustained-release formulation of tramadol in patients suffering from osteoarthritis or from refractory chronic low back pain. 2-9-2003: Prague, EFIC. Abstract no. 344T. Proceeding of the 4th Congress of the EFIC.